Bladder cancer risk as modified by family history and smoking

Cancer

Volumn 107, Issue 4, 2006, Pages 705-711

  Lin, Jie ^a   Spitz, Margaret R ^a   Dinney, Colin P ^a   Etzel, Carol J ^a   Grossman, H Barton ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bladder cancer; Familial risk; Proband; Smoking

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELATIVE; RISK FACTOR; RISK REDUCTION; SMOKING; SMOKING HABIT;

AGED; CASE-CONTROL STUDIES; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; RISK FACTORS; SMOKING; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 33747168789     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22071     Document Type: Article

References (28)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
2. Lynch H, Walzak M, Fried R, Domina A, Lynch J. Familial factors in bladder carcinoma. J Urol. 1979;122:458-461.
3. Fraumeni JF Jr, Thomas LB. Malignant bladder tumors in a man and his three sons. JAMA. 1967;201:97-99.
4. Mahboubi A, Ahlvin R, Mahboubi E. Familial aggregation of urothelial carcinoma. J Urol. 1981;126:691-692.
5. Mccullough DL, Lama DL, Mclaughlin AP, Gittes RP. Familial transitional cell carcinoma of the bladder. J Urol. 1975;113:629-635.
6. Kramer A, Graham S, Burnett W, Nasca P. Familial aggregation of bladder cancer stratified by smoking status. Epidemiology. 1991;2:145-148.
7. Aben KKH, Witjes JA, Schoenberg MP, Hulsberger-Van De Kaa C, Verbeek A, Kiemeney L. Familial aggregation of urothelial cell carcinoma. Int J Cancer. 2002;98:274-278.
8. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst. 1994;86:1600-1608.
9. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer. Analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78-85.
10. Hemminki K, Vaittinen P. Familial cancers in a nationwide family cancer database: age distribution and prevalence. Eur J Cancer. 1999;35:1109-1117.
11. Kiemeney LA, Moret NC, Witjes JA, Scheonberg MP, Tulinius H. Familial transitional cell carcinoma among the population of Iceland. Urology. 1997;157:1649-1651.
12. Etzel CJ, Amos CI, Spitz MR. Risk for smoking-related cancer among relatives of lung cancer patients. Cancer Res. 2003;63:8531-8535.
13. Fernandez E, La Vecchia C, D'Avanzo B, Negri E, Franceschi S. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 1994;3:209-212.
14. Schenk M, Schwartz AG, O'Neal E, et al. Familial risk of pancreatic cancer. J Natl Cancer Inst. 2001;93:640-644.
15. Schwartz AG, Yang P, Swanson GM. Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol. 1996;144:554-562.
16. Liang KY, Beaty TH. Statistical designs for familial aggregation. Stat Methods Med Res. 2000;9:543-562.
17. Zeger SI, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130.
18. Lynch HT, Ens JA, Lynch JF. The Lynch syndrome II and urological malignancies. J Urol. 1990;143:24-28.
19. Greenland JE, Weston PMT, Wallace DMA. Familial transitional cell carcinoma and the Lynch syndrome II. Br J Urol. 1993;72:177-180.
20. Lynch HT, Lanspa S, Smyrk T, Boman B, Watson P, Lynch J. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). Genetics, pathology, natural history, and cancer control, part I. Cancer Genet Cytogenet. 1991;53:143-160.
21. Kantor A, Hartge P, Hoover R, Fraumeni J Jr. Familial and environmental interactions in bladder cancer risk. Int J Cancer. 1985;35:703-706.
22. Plna K, Hemminki K. Familial bladder cancer in the National Swedish Family Cancer Database. J Urol. 2001;166:2129-2133.
23. Love RR, Evans AM, Josten DM. The accuracy of patient reports of family history of cancer. J Chronic Dis. 1985;38:289-293.
24. Bondy ML, Strom SS, Colopy MW, Brown BW, Strong LC. Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol. 1994;47:89-96.
25. Ziogas A, Anton-Culver H. Validation of family data in cancer family registries. J Prev Med. 2003;24:190-198.
26. Boyle CA, Brann EA. Proxy respondents and the validity of occupational and other exposure data. The Selected Cancers Cooperative Study Group. Am J Epidemiol. 1992;136:712-721.
27. Sandler DP, Shore DL. Quality of data on parents' smoking and drinking provided by adult offspring. Am J Epidemiol. 1986;124:768-778.
28. McLaughlin JK, Dietz MS, Mehl ES, Blot WJ. Reliability of surrogate information on cigarette smoking by type of information. Am J Epidemiol. 1987;126:144-146.